Alzheimer's Disease and Related DementiaDERANCT07545577
Randomized Controlld Trial of Dementia Education Resources for Action
A study testing DERA Online Training Program in people with Alzheimer's Disease and Related Dementia, run by George Mason University at 1 site in United States.
Trial summary
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Alzheimer's Disease and Related Dementia
- What is being tested?
- DERA Online Training Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Jun 2026to 31 Aug 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18 years or older
- Currently working as a community health worker or serving in a community health worker-related role
- Able to read and understand English
- Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
- Willing and able to provide informed consent
Who cannot join
- Previously completed the DERA training program
- Unable to complete study procedures in English
- Unable to access the online training platform or study surveys
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Online
Fairfax, Virginia, 22030
Alicia Hong, 703-993-1929, yhong22@gmu.edu
yhong22@gmu.edu
About this study
Official title: Evaluation of Dementia Education and Resources for Action
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
- Conditions
- Alzheimer's Disease and Related Dementia
- Being tested
- DERA Online Training Program
- Keywords
- Community Health Workers, ADRD, Self-efficacy, Stigma, Digital Health Intervention
- Medical subject headings
- Alzheimer Disease, Social Stigma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DERA Online Training ProgramBehavioural
The Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.
| Study group | Role | What they receive |
|---|---|---|
| Immediate DERA Intervention | Experimental | Participants assigned to this arm will receive immediate access to the DERA online training program. The program is web-based platform and includes 7 structured modules on dementia knowledge, stigma reduction, and the role of community health workers in supporting individuals with dementia and their caregivers. Receives: Behavioral: DERA Online Training Program |
| Waitlist Control | No intervention | Participants assigned to this arm will not receive access to the DERA program during the study period. They will complete baseline and post-intervention assessments over a similar timeframe as the intervention group. After completion of the post-intervention assessment, participants will be provided access to the DERA training program. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dementia Knowledge
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Secondary outcomes (2)
Dementia-Related Stigma
Dementia-related stigma will be assessed using an adapted 8-item stigma scale with response options ranging from strongly disagree to strongly agree. Total scores range from 8 to 40, with higher scores indicating greater dementia-related stigma.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Self-Efficacy in Dementia Care
Self-efficacy will be measured using a study-specific Community Health Worker Dementia Role Self-Efficacy Scale assessing confidence in performing dementia-related tasks, including education, communication, support, and service navigation. Response options range from "Not at all confident" to "Extremely confident." Total scores range from 8 to 40, with higher scores indicating greater self-efficacy in dementia-related service delivery.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2026
- Study start16 Jun 2026
- Primary completion30 Dec 2026 (estimated)
- Study completion31 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alzheimer's Disease and Related DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- George Mason University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Y. Alicia Hong, George Mason University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07545577
- Sponsor's protocol ID
- STUDY00000621
- Acronym
- DERA
- Status last verified
- May 2026
- First submitted
- 16 Apr 2026
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be publicly shared due to privacy considerations. De-identified data may be made available upon reasonable request to the study investigators, subject to institutional review and data use agreements.